Role of Akt/GSK-3β/β-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats

Endocrinology

Volumn 149, Issue 8, 2008, Pages 3900-3908

  Schakman, Olivier ^a,c   Kalista, S ^a   Bertrand, L ^b   Lause, P ^a   Verniers, J ^a   Ketelslegers, J M ^a   Thissen, J P ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b Cardiology Unit   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DEXAMETHASONE; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; MALE; MOLECULAR MIMICRY; MUSCLE ATROPHY; MUSCLE HYPERTROPHY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT;

ANIMALS; BETA CATENIN; CYTOPROTECTION; DEXAMETHASONE; GLUCOCORTICOIDS; GLYCOGEN SYNTHASE KINASE 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCULAR ATROPHY; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 47949109779     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0439     Document Type: Article

References (55)

1. Lecker SH, Solomon V, Mitch WE, Goldberg AL 1999 Muscle protein breakdown and the critical role of the ubiquitin- proteasome pathway in normal and disease states. J Nutr 129(Suppl):227S-237S
2. Hasselgren PO 1999 Glucocorticoids and muscle catabolism. Curr Opin Clin Nutr Metab Care 2:201-205
3. Tomas FM, Munro HN, Young VR 1979 Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of N τ-methylhistidine. Biochem J 178:139-146
4. Goldberg AL, Tischler M, DeMartino G, Griffin G 1980 Hormonal regulation of protein degradation and synthesis in skeletal muscle. Fed Proc 39:31-36
5. Lofberg E, Gutierrez A, Wernerman J, Anderstam B, Mitch WE, Price SR, Bergstrom J, Alvestrand A 2002 Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle. Eur J Clin Invest 32:345-353
6. Schakman O, Gilson H, and Thissen JP 2008 Mechanisms of glucocorticoid-induced myopathy. J Endocrinol 2008 197:1-10
7. Shah OJ, Kimball SR, Jefferson LS 2000 Acute attenuation of translation initiation and protein synthesis by glucocorticoids in skeletal muscle. Am J Physiol Endocrinol Metab 278:E76-E82
8. Shah OJ, Kimball SR, Jefferson LS 2000 Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoids. Biochem J 347(Pt 2):389-397
9. Liu ZQ, Jahn LA, Long W, Fryburg DA, Wei LP, Barrett EJ 2001 Branched chain amino acids activate messenger ribonucleic acid translation regulatory proteins in human skeletal muscle, and glucocorticoids blunt this action. J Clin Endocrinol Metab 86:2136-2143
10. Liu Z, Li G, Kimball SR, Jahn LA, Barrett EJ 2004 Glucocorticoids modulate amino acid-induced translation initiation in human skeletal muscle. Am J Physiol Endocrinol Metab 287:E275-E281
11. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na EQ, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ 2001 Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704-1708
12. Mitch WE, Goldberg AL 1996 Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335:1897-1905
13. Combaret L, Adegoke OA, Bedard N, Baracos V, Attaix D, Wing SS 2005 USP19 is a ubiquitin-specific protease regulated in rat skeletal muscle during catabolic states. Am J Physiol Endocrinol Metab 288:E693-E700
14. Deval D, Mordier S, Obled C, Bechet D, Combaret L, Attaix D, Ferrara M 2001 Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting. Biochem J 360(Pt 1):143-150
15. Komamura K, Shirotani-Ikejima H, Tatsumi R, Tsujita-Kuroda Y, Kitakaze M, Miyatake K, Sunagawa K, Miyata T 2003 Differential gene expression in the rat skeletal and heart muscle in glucocorticoid-induced myopathy: analysis by microarray. Cardiovasc Drugs Ther 17:303-310
16. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL 2004 IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 287:E591-E601
17. Gayan-Ramirez G, Vanderhoydonc F, Verhoeven G, Decramer M 1999 Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius. Am J Respir Crit Care Med 159:283-289
18. Florini JR, Ewton DZ, Coolican SA 1996 Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17:481-517
19. Frost RA, Lang CH 2003 Regulation of insulin-like growth factor-I in skeletal muscle and muscle cells. Minerva Endocrinol 28:53-73
20. Adamo M, Werner H, Farnsworth W, Roberts Jr CT, Raizada M, LeRoith D 1988 Dexamethasone reduces steady state insulin-like growth factor I messenger ribonucleic acid levels in rat neuronal and glial cells in primary culture. Endocrinology 123:2565-2570
21. Dehoux M, Van Beneden R, Pasko N, Lause P, Verniers J, Underwood L, Ketelslegers JM, Thissen JP 2004 Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes. Endocrinology 145:4806-4812
22. Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin HC, Yancopoulos GD, Glass DJ 2005 Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280:2737-2744
23. Li ZF, Shelton GD, Engvall E 2005 Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality. Am J Pathol 166:491-497
24. Li BG, Hasselgren PO, Fang CH 2005 Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3β and PI3K/Akt/mTOR-dependent mechanisms. Int J Biochem Cell Biol 37:2207-2216
25. Tomas FM 1998 The anti-catabolic efficacy of insulin-like growth factor-I is enhanced by its early administration to rats receiving dexamethasone. J Endocrinol 157:89-97
26. Kanda F, Takatani K, Okuda S, Matsushita T, Chihara K 1999 Preventive effects of insulinlike growth factor-I on steroid- induced muscle atrophy. Muscle Nerve 22:213-217
27. Fournier M, Huang ZS, Li H, Da X, Cercek B, Lewis MI 2003 Insulin-like growth factor-I prevents corticosteroid-induced diaphragm muscle atrophy in emphysematous hamsters. Am J Physiol Regul Integr Comp Physiol 285:R34-R43
28. Tomas FM, Knowles SE, Owens PC, Chandler CS, Francis GL, Read LC, Ballard FJ 1992 Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. Biochem J 282(Pt 1):91-97
29. Schakman O, Gilson H, de Coninck V, Lause P, Verniers J, Havaux X, Ketelslegers JM, Thissen JP 2005 Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats. Endocrinology 146:1789-1797
30. Alzghoul MB, Gerrard D, Watkins BA, Hannon K 2004 Ectopic expression of IGF-I and Shh by skeletal muscle inhibits disuse-mediated skeletal muscle atrophy and bone osteopenia in vivo. FASEB J 18:221-223
31. Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B, Woodgett J, Kilter H, Force T 2003 Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci USA 100:4610-4615
32. Hajduch E, Alessi DR, Hemmings BA, Hundal HS 1998 Constitutive activation of protein kinase B α by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes 47:1006-1013
33. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ 2001 Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3:1009-1013
34. Schakman O, de Conninck V, Verniers J, Gilson H, Ketelslegers JM, Thissen JP IGF-I gene transfer by electroporation promotes skeletal muscle hypertrophy in hypophysectomized rats. Program of the 86th Annual Meeting of The Endocrine Society, New Orleans, LA, 2004 (Abstract P3-187)
35. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD 2001 Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014-1019
36. Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S 2002 A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA 99:9213-9218
37. Cleasby ME, Reinten TA, Cooney GJ, James DE, Kraegen EW 2007 Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. Mol Endocrinol 21:215-228
38. Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ 2004 Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 24:9295-9304
39. Fang CH, Li B, James JH, Yahya A, Kadeer N, Guo X, Xiao C, Supp DM, Kagan RJ, Hasselgren PO, Sheriff S 2007 GSK-3β activity is increased in skeletal muscle after burn injury in rats. Am J Physiol Regul Integr Comp Physiol 293:R1545-R1551
40. Glass DJ 2003 Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 5:87-90
41. Shah OJ, Anthony JC, Kimball SR, Jefferson LS 2000 Glucocorticoids oppose translational control by leucine in skeletal muscle. Am J Physiol Endocrinol Metab 279:E1185-E1190
42. Shah OJ, Anthony JC, Kimball SR, Jefferson LS 2000 4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle. Am J Physiol Endocrinol Metab 279:E715-E729
43. Wang H, Kubica N, Ellisen LW, Jefferson LS, Kimball SR 2006 Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J Biol Chem 281:39128-39134
44. Ohanna M, Sobering AK, Lapointe T, Lorenzo L, Praud C, Petroulakis E, Sonenberg N, Kelly PA, Sotiropoulos A, Pende M 2005 Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol 7:286-294
45. Evenson AR, Fareed MU, Menconi MJ, Mitchell JC, Hasselgren PO 2005 GSK-3β inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes. Int J Biochem Cell Biol 37:2226-2238
46. Armstrong DD, Wong VL, Esser KA 2006 Expression of β-catenin is necessary for physiological growth of adult skeletal muscle. Am J Physiol Cell Physiol 291:C185-C188
47. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R 1997 β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16:3797-3804
48. Cohen P, Frame S 2001 The renaissance of GSK3. Nat Rev Mol Cell Biol 2:769-776
49. Playford MP, Bicknell D, Bodmer WF, Macaulay VM 2000 Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of β-catenin. Proc Natl Acad Sci USA 97:12103-12108
50. Hecht A, Kemler R 2000 Curbing the nuclear activities of β-catenin. Control over Wnt target gene expression. EMBO Rep 1:24-28
51. Pan W, Jia Y, Wang J, Tao D, Gan X, Tsiokas L, Jing N, Wu D, Li L 2005 β-Catenin regulates myogenesis by relieving I-mfa-mediated suppression of myogenic regulatory factors in P19 cells. Proc Natl Acad Sci USA 102:17378-17383
52. Brunelli S, Relaix F, Baesso S, Buckingham M, Cossu G 2007 β-Catenin-independent activation of MyoD in presomitic mesoderm requires PKC and depends on Pax3 transcriptional activity. Dev Biol 304:604-614
53. Longo KA, Kennell JA, Ochocinska MJ, Ross SE, Wright WS, MacDougald OA 2002 Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J Biol Chem 277:38239-38244
54. Huang M, Wang Y, Sun D, Zhu H, Yin Y, Zhang W, Yang S, Quan L, Bai J, Wang S, Chen Q, Li S, Xu N 2006 Identification of genes regulated by Wnt/β-catenin pathway and involved in apoptosis via microarray analysis. BMC Cancer 6:221
55. Willert J, Epping M, Pollack JR, Brown PO, Nusse R 2002 A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2:8